Capecitabine and oxaliplatin in combination as first or second-line therapy for metastatic breast cancer: A Wisconsin Oncology Network trial

PURPOSE: Several cytotoxic chemotherapy regimens are active against metastatic breast cancer; however, benefits are modest and overall prognosis remains limited. For anthracycline and taxane-pretreated metastatic breast cancer, there remains a relative paucity of therapies with significant activity....

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Njiaju, U.O., Tevaarwerk, A.J., Kim, K., Chang, J.E., Hansen, R.M., Champeny, T.L., Traynor, A.M., Meadows, S., Van Ummersen, L., Powers, K., Stewart, J.A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2012
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3581759/
https://ncbi.nlm.nih.gov/pubmed/23228989
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-012-2044-2
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak